As demand for precision medicine accelerates, CAR T and CAR Treg cell therapies are emerging as crucial tools in the fight against cancer and autoimmune diseases. For Thomas Fellner, PhD, head of ...
Cryopreserved leukapheresis is a scalable source for Chimeric antigen receptor T (CAR-T) manufacturing, yet it remains understudied (18.3% of 349 studies, 2010–2024). Current challenges include that ...
Avantor AVTR recently entered into a strategic partnership with BlueWhale Bio to accelerate innovation in CAR-T cell therapy manufacturing. The collaboration merges Avantor’s bioprocessing expertise ...
Fresenius Kabi and Charles River are among 18 partners in a new EU-backed consortium that aims to develop an automated, hospital-based manufacturing platform for CAR-T therapies. (ljubaphoto/Getty ...
We have curated a list of in vivo CAR T biotech companies in preclinical and clinical stages that you should keep an eye out ...
Quality by design is critical for cell and gene therapy manufacturing where process controls directly influence product ...
Avantor entered a strategic partnership with BlueWhale Bio to advance CAR-T manufacturing. The collaboration merges Avantor's bioprocessing expertise with BlueWhale's CDNP technology. The deal targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results